Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312040147> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W4312040147 abstract "In French Polynesia, Wuhan, Delta and Omicron SARS-CoV-2 variants-of-concern (VOCs) caused epidemics with variable severities. We assessed the prevalence and titers of anti-SARS-CoV-2 antibodies related to natural infection and/or vaccination, from a representative sample (N=673) of the adult population of Tahiti recruited during November-December 2021 (after the Delta outbreak and just before the Omicron epidemic). Of the 673 participants tested, 644 (95.7%) had detectable antibodies against SARS-CoV-2-S and/or -N proteins resulting from natural infection and/or vaccination, and 388 (57.7%) were positive only for the detection of anti-N antibodies indicating natural infection. SARS-CoV-2 seroprevalence extrapolated to the adult population of Tahiti was estimated at 95.9%. Concentrations of anti-SARS-CoV-2-S antibodies significantly increased with age, number of self-reported SARS-CoV-2 infections (0 or ≥1), and number of COVID-19 vaccine doses (0, 1, 2, or 3) received by the participants. Elderly people, who are at higher risk of severe outcomes, had received more vaccine doses than younger individuals both in our sample and in the general population. The high level of antibody responses related to past infections and vaccination, especially booster doses, has likely contributed to reducing the severity of the Omicron outbreak in French Polynesia." @default.
- W4312040147 created "2023-01-04" @default.
- W4312040147 creator A5005041583 @default.
- W4312040147 creator A5012933074 @default.
- W4312040147 creator A5041215248 @default.
- W4312040147 creator A5049266938 @default.
- W4312040147 creator A5053430318 @default.
- W4312040147 creator A5054035411 @default.
- W4312040147 creator A5059470545 @default.
- W4312040147 creator A5063834923 @default.
- W4312040147 creator A5082535176 @default.
- W4312040147 creator A5082569379 @default.
- W4312040147 creator A5087125238 @default.
- W4312040147 date "2022-12-21" @default.
- W4312040147 modified "2023-09-26" @default.
- W4312040147 title "Seroprevalence of SARS-CoV-2 Antibodies in French Polynesia and Perspective for Vaccine Strategies" @default.
- W4312040147 doi "https://doi.org/10.20944/preprints202212.0386.v1" @default.
- W4312040147 hasPublicationYear "2022" @default.
- W4312040147 type Work @default.
- W4312040147 citedByCount "1" @default.
- W4312040147 countsByYear W43120401472023 @default.
- W4312040147 crossrefType "posted-content" @default.
- W4312040147 hasAuthorship W4312040147A5005041583 @default.
- W4312040147 hasAuthorship W4312040147A5012933074 @default.
- W4312040147 hasAuthorship W4312040147A5041215248 @default.
- W4312040147 hasAuthorship W4312040147A5049266938 @default.
- W4312040147 hasAuthorship W4312040147A5053430318 @default.
- W4312040147 hasAuthorship W4312040147A5054035411 @default.
- W4312040147 hasAuthorship W4312040147A5059470545 @default.
- W4312040147 hasAuthorship W4312040147A5063834923 @default.
- W4312040147 hasAuthorship W4312040147A5082535176 @default.
- W4312040147 hasAuthorship W4312040147A5082569379 @default.
- W4312040147 hasAuthorship W4312040147A5087125238 @default.
- W4312040147 hasBestOaLocation W43120401471 @default.
- W4312040147 hasConcept C116675565 @default.
- W4312040147 hasConcept C126322002 @default.
- W4312040147 hasConcept C144024400 @default.
- W4312040147 hasConcept C149923435 @default.
- W4312040147 hasConcept C159047783 @default.
- W4312040147 hasConcept C159654299 @default.
- W4312040147 hasConcept C203014093 @default.
- W4312040147 hasConcept C22070199 @default.
- W4312040147 hasConcept C2778494684 @default.
- W4312040147 hasConcept C2779134260 @default.
- W4312040147 hasConcept C2908647359 @default.
- W4312040147 hasConcept C3007834351 @default.
- W4312040147 hasConcept C3008058167 @default.
- W4312040147 hasConcept C32611913 @default.
- W4312040147 hasConcept C45189115 @default.
- W4312040147 hasConcept C524204448 @default.
- W4312040147 hasConcept C71924100 @default.
- W4312040147 hasConcept C99454951 @default.
- W4312040147 hasConceptScore W4312040147C116675565 @default.
- W4312040147 hasConceptScore W4312040147C126322002 @default.
- W4312040147 hasConceptScore W4312040147C144024400 @default.
- W4312040147 hasConceptScore W4312040147C149923435 @default.
- W4312040147 hasConceptScore W4312040147C159047783 @default.
- W4312040147 hasConceptScore W4312040147C159654299 @default.
- W4312040147 hasConceptScore W4312040147C203014093 @default.
- W4312040147 hasConceptScore W4312040147C22070199 @default.
- W4312040147 hasConceptScore W4312040147C2778494684 @default.
- W4312040147 hasConceptScore W4312040147C2779134260 @default.
- W4312040147 hasConceptScore W4312040147C2908647359 @default.
- W4312040147 hasConceptScore W4312040147C3007834351 @default.
- W4312040147 hasConceptScore W4312040147C3008058167 @default.
- W4312040147 hasConceptScore W4312040147C32611913 @default.
- W4312040147 hasConceptScore W4312040147C45189115 @default.
- W4312040147 hasConceptScore W4312040147C524204448 @default.
- W4312040147 hasConceptScore W4312040147C71924100 @default.
- W4312040147 hasConceptScore W4312040147C99454951 @default.
- W4312040147 hasLocation W43120401471 @default.
- W4312040147 hasOpenAccess W4312040147 @default.
- W4312040147 hasPrimaryLocation W43120401471 @default.
- W4312040147 hasRelatedWork W1968120732 @default.
- W4312040147 hasRelatedWork W1984647379 @default.
- W4312040147 hasRelatedWork W3014337446 @default.
- W4312040147 hasRelatedWork W3025588727 @default.
- W4312040147 hasRelatedWork W3031696803 @default.
- W4312040147 hasRelatedWork W3127693599 @default.
- W4312040147 hasRelatedWork W3196541986 @default.
- W4312040147 hasRelatedWork W3202879662 @default.
- W4312040147 hasRelatedWork W4210401150 @default.
- W4312040147 hasRelatedWork W4385264226 @default.
- W4312040147 isParatext "false" @default.
- W4312040147 isRetracted "false" @default.
- W4312040147 workType "article" @default.